Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 18”

51 trials

Showing 20 of 51 results

Large-scale testing (Phase 3)Study completedNCT04526990
What this trial is testing

Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above

Who this might be right for
COVID-19
CanSino Biologics Inc. 44,247
Testing effectiveness (Phase 2)Study completedNCT03919669
What this trial is testing

A Longitudinal Evaluation of a Radiotracer for Use in Tau Tracking

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
University of Wisconsin, Madison 27
Testing effectiveness (Phase 2)WithdrawnNCT02707978
What this trial is testing

F 18 T807 Tau PET Imaging of Frontotemporal Dementia (FTD)

Who this might be right for
Alzheimer Disease
Tammie L. S. Benzinger, MD, PhD
Not applicableStudy completedNCT01565369
What this trial is testing

Evaluation of Physician Training Methods to Read Florbetapir-PET Scans

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 35
Large-scale testing (Phase 3)WithdrawnNCT05124561
What this trial is testing

Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)

Who this might be right for
COVID-19
CanSino Biologics Inc.
Early research (Phase 1)Study completedNCT01009359
What this trial is testing

Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy Volunteers

Who this might be right for
Diagnostic Imaging
Bayer 22
Testing effectiveness (Phase 2)Ended earlyNCT01712074
What this trial is testing

Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil

Who this might be right for
Alzheimer's Disease
Pfizer 186
Testing effectiveness (Phase 2)UnknownNCT04398147
What this trial is testing

Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada

Who this might be right for
COVID-19
CanSino Biologics Inc. 696
Large-scale testing (Phase 3)Study completedNCT01689233
What this trial is testing

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
TauRx Therapeutics Ltd 800
Testing effectiveness (Phase 2)Study completedNCT02278367
What this trial is testing

Clinical Evaluation of Flortaucipir F 18

Who this might be right for
Alzheimer's DiseaseTraumatic Brain InjuryDepression
Avid Radiopharmaceuticals 179
Testing effectiveness (Phase 2)Study completedNCT03322462
What this trial is testing

Tau Screening Study in Patients With Early Symptomatic AD

Who this might be right for
Alzheimer Disease
Avid Radiopharmaceuticals 155
Large-scale testing (Phase 3)Active Not RecruitingNCT06709014
What this trial is testing

Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

Who this might be right for
Early Alzheimers Disease
Annovis Bio Inc. 760
Testing effectiveness (Phase 2)Study completedNCT00855868
What this trial is testing

Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 28
Early research (Phase 1)Study completedNCT01565330
What this trial is testing

Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers

Who this might be right for
Alzheimer Disease
Avid Radiopharmaceuticals 20
Large-scale testing (Phase 3)Study completedNCT01447719
What this trial is testing

Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 110
Large-scale testing (Phase 3)Active Not RecruitingNCT03887455
What this trial is testing

Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

Who this might be right for
Early Alzheimer's Disease
Eisai Inc. 1,906
Not applicableStudy completedNCT04726527
What this trial is testing

Clinical Evaluation of Florbetapir in Primary Progressive Aphasia

Who this might be right for
Primary Progressive AphasiaAlzheimer DiseaseDementia
University of Chicago 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT05531656
What this trial is testing

Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease

Who this might be right for
Early Alzheimer's Disease
Cognition Therapeutics 540
Large-scale testing (Phase 3)Study completedNCT00103649
What this trial is testing

18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Sanofi 1,306
Early research (Phase 1)Study completedNCT01564706
What this trial is testing

18F-AV-45 in Healthy Volunteers

Who this might be right for
Alzheimer Disease
Avid Radiopharmaceuticals 9
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation